Fecal Microbiota Transplant Mitigates Adverse Outcomes Seen in Patients Colonized With Multidrug-Resistant Organisms Undergoing Allogeneic Hematopoietic Cell Transplantation.

导出 LinkOut

翻译打印收藏纠错

作者： Andrew J,Innes ^[1] ; Benjamin H,Mullish ^[2] ; Rohma,Ghani ^[2] ; Richard M,Szydlo ^[1] ; Jane F,Apperley ^[1] ; Eduardo,Olavarria ^[1] ; Renuka,Palanicawandar ^[1] ; Edward J,Kanfer ^[1] ; Dragana,Milojkovic ^[1] ; Julie A K,McDonald ^[3] ; Eimear T,Brannigan ^[4] ; Mark R,Thursz ^[2] ; Horace R T,Williams ^[2] ; Frances J,Davies ^[3] ; Julian R,Marchesi ^[2] ; Jiří,Pavlů ^[1]

作者单位： Centre for Haematology, Imperial College London at Hammersmith Hospital, London, United Kingdom. ^[1] Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom. ^[2] Medical Research Council (MRC) Centre for Molecular Bacteriology and Infection, Imperial College London, London, United Kingdom. ^[3] National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, United Kingdom. ^[4]

关键词 antimicrobial resistance fecal microbiota transplant gut microbiota hematological malignances hematopoietic (Stem) cell transplantation (HCT)multidrug resistant bacteria

主题词抗药性, 多种, 细菌(Drug Resistance, Multiple, Bacterial);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);回顾性研究(Retrospective Studies)

DOI 10.3389/fcimb.2021.684659

PMID 34513724

发布时间 2022-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交